Bernard J Cassidy has sold JUNO and made no open-market buys since Jan 2016

Bernard J. “Barney” Cassidy is a corporate attorney and biotechnology executive who served as General Counsel and Corporate Secretary of Juno Therapeutics, Inc. (JUNO), where he was also a reporting corporate insider engaged in equity transactions in the company’s stock.( As Juno’s chief legal officer, he oversaw the company’s legal, corporate governance, and compliance functions through its growth as a public biotechnology company and during its acquisition by Celgene in early 2018.( His insider filings with the U.S. Securities and Exchange Commission identify him as General Counsel and Corporate Secretary of Juno Therapeutics, Inc., confirming his role as an individual officer rather than a corporate entity.(

Prior to joining Juno Therapeutics, Cassidy served as Executive Vice President, General Counsel, and Secretary of Tessera Technologies, where he led legal and intellectual property strategy for a technology and IP licensing business.( Following Juno’s acquisition, he advised the U.S. Patent and Trademark Office as a member of the Patent Public Advisory Committee (PPAC), reflecting his expertise in patent, life sciences, and innovation policy.( Public biographical materials describe him as holding a Juris Doctor (JD) and practicing at the executive level in corporate and IP-focused legal roles, although specific details on his undergraduate institution and year of graduation are not disclosed in the available public filings.(

Written by Perplexity from public sources.